Early research (Phase 1)Study completedNCT00517543
What this trial is testing
Examine the Effect of Particle Size on Bioequivalence and Bioavailability
Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Rheumatoid ArthritisAtherosclerosis
GlaxoSmithKline 36